Industry news

Share this article:
GlaxoSmithKline is partnering with the Healthcare Communication & Marketing Association (HCMA) to provide education, training and support to members on its Value of Medicine Program, aimed at getting the industry's side out on issues including drug costs, marketing and promotion, drug importation, drug safety and the Medicare prescription drug benefit. “HCMA members hold key marketing and education positions in the industry,” said Jay Bolling, president of HCMA and president of Roska Healthcare Advertising. “This strategic partnership with GSK will provide our members with the tools and information necessary to repair the perception the healthcare profession and patients have of our industry.”
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.

Painkiller maker Acura gets NIH grant

The $300,000 grant will go towards an abuse-deterrent technology.

Biologics have higher psoriatic arthritis adherence

A study of psoriatic arthritis patients found greater adherence among patients whose initial treatment was a biologic, compared to those who started with a non-biologic treatment.